ArticleAmerican journal of stem cells2022

Phase 1 clinical trial for intravenous administration of mesenchymal stem cells derived from umbilical cord and placenta in patients with moderate COVID-19 virus pneumonia: results of stage 1 of the study.

Alok Sharma et al.PubMed ↗Full text ↗

No numbers read from the abstract.